CorMedix Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
CorMedix Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • CorMedix Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $70.8M, a 22.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $70.8M +$13M +22.5% Dec 31, 2023 10-K 2024-03-12
Q4 2022 $57.8M +$4.77M +9.01% Dec 31, 2022 10-K 2024-03-12
Q4 2021 $53M +$4.51M +9.3% Dec 31, 2021 10-K 2024-03-12
Q4 2020 $48.5M +$2.67M +5.82% Dec 31, 2020 10-K 2023-03-30
Q4 2019 $45.8M +$2.42M +5.57% Dec 31, 2019 10-K 2022-03-29
Q4 2018 $43.4M +$7.05M +19.4% Dec 31, 2018 10-K 2021-03-30
Q4 2017 $36.3M -$1.47M -3.88% Dec 31, 2017 10-K 2020-03-16
Q4 2016 $37.8M +$11.3M +42.5% Dec 31, 2016 10-K 2018-03-19
Q4 2015 $26.5M +$7.78M +41.5% Dec 31, 2015 10-K 2018-03-19
Q4 2014 $18.7M +$2.18M +13.2% Dec 31, 2014 10-K 2017-03-16
Q4 2013 $16.6M +$3.03M +22.4% Dec 31, 2013 10-K 2017-03-16
Q4 2012 $13.5M +$25.7M Dec 31, 2012 10-K 2015-03-12
Q4 2011 -$12.2M Dec 31, 2011 10-K/A 2014-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.